|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 233/54 | (2006.01) |
| A61K 31/417 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 1725537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05728171.9 |
| Date of filing the European patent application | 2005-03-14 | |
| (97) | Date of publication of the European application | 2006-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2011-07-13 |
| (46) | Date of publication of the claims translation | 2011-11-25 |
| (86) | Number | PCT/US2005/008339 |
| Date | 2005-03-14 |
| (87) | Number | WO 2005/090315 |
| Date | 2005-09-29 |
| (30) | Number | Date | Country code |
| 553342 P | 2004-03-15 | US |
| (72) |
BRESLIN, Henry, J., US
CAI, Chaozhong, US
HE, Wei, US
KAVASH, Robert, W., US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji junginiai, kaip opioido receptoriaus moduliatoriai |
| NOVEL COMPOUNDS AS OPIOID RECEPTOR MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2022-03-01 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-14 |